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1. SUMMARY 
 
Urine reference materials used in interlaboratory comparison must be homogeneous and 
stable over time. The lyophilisation process is one of the methods applied when preparing urine 
reference materials for ensuring stability during distribution, transport and storage. Urine 
samples of 11- nor- Δ9- tetrahydrocannabinol- 9- carboxylic acid (THC-COOH), 
Benzoylecgonine (BE), Ethyl glucuronide/Ethyl sulphate (EtG/EtS) and ethanol (EtOH) were 
prepared from blank urine previously filtered. Samples were fortified with the adequate standard 
solutions and they were divided in aliquots. Aliquots stored at 4 ºC and lyophilized aliquots were 
used to evaluate the homogeneity of the samples. Others were frozen at -20 ºC and they were 
used as reference aliquots. 
In the first analysis, all prepared samples, except EtOH sample, were considered 
homogeneous. Concentration differences of THC-COOH and BE between lyophilized aliquots 
and reference aliquots were minimum (lower than 5 %). However, differences higher than 8 % 
were observed for EtG/EtS. If these differences were maintained constant in subsequence 
quantifications, they could be attributed to the evaporation of the analytes during the 
lyophilisation process. Results obtained for EtOH sample show a completely loss of the analyte 
due to its high volatility. 
Keywords: Drugs of abuse, lyophilized urine, doping, GC/MS, LC/MS-MS 
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2. RESUMEN 
En  los ejercicios interlaboratorio deben utilizarse materiales de referencia que sean 
homogéneos y estables a lo largo del tiempo. El proceso de liofilización es uno de los métodos 
utilizados para preparar materiales de referencia de orina y asegurar su estabilidad durante su 
distribución, transporte y almacenaje. Se prepararon muestras de orina conteniendo: ácido 11- 
nor- Δ9- tetrahidrocannabinol- 9- carboxilico (THC-COOH), Benzoilecgonina (BE), Etil 
glucurónido/Etil sulfato (EtG/EtS) y Etanol (EtOH), a partir de un blanco de orina previamente 
filtrado. Las muestras se fortificaron con las soluciones estándar adecuadas y se dividieron en 
alícuotas. Las alícuotas almacenadas  a 4 ºC y las liofilizadas se utilizaron para evaluar la 
homogeneidad de las muestras. Otras se congelaron a -20 ºC y se utilizaron como alícuotas de 
referencia.  
 En el primer análisis se observó que para los analitos estudiados, excepto para el EtOH, 
las muestras eran homogéneas. Los diferencias en concentración de THC-COOH y BE de las 
alícuotas liofilizadas respecto las de referencia fueron mínimas (menores al 5 %). En cambio, 
para EtG/EtS se observaron diferencias superiores al 8 %. Si estas diferencias se mantuvieran 
constantes en cuantificaciones posteriores, éstas se podrían atribuir a la evaporación de los 
analitos durante el proceso de liofilización. Los resultados obtenidos para la muestra de EtOH 
revelan una completa pérdida del analito durante la liofilización debido a la gran volatilidad de 
éste. 
Palabras clave: Drogas de abuso, orina liofilizada, dopaje, CG/EM, CL/EM-EM
Preparation of reference materials for anti-doping control: study of the lyophilisation conditions.  7 
 
3. INTRODUCTION 
Nowadays, to work as a laboratory of anti-doping is essential to be accredited by ISO 17025 
and by WADA (World Anti-Doping Agency)[1].Currently, there are 32 laboratories around the 
world accredited by WADA to conduct human doping control sample analyses. While most 
WADA-accredited laboratories can also perform blood analyses in support of the 
haematological module of the Athlete Biological Passport (ABP), there are currently an 
additional 5 approved laboratories (non WADA-accredited laboratories) that are also permitted 
to conduct such analyses[1]. In Spain, there are two accredited laboratories, Madrid Anti-Doping 
Laboratory and Fundació Institut del Mar d'Investigacions Mèdiques (IMIM)[2] where this project 
has been performed. 
Participation in interlaboratory comparisons and the regular use of reference material are 
two of the requirements of testing laboratories to assure the quality of analytical results 
according to international quality standards such as ISO 17025. It is important to verify 
homogeneity and drug stability from production until end-use to be sure that differences in 
results between laboratories are not related to drug instability or the lack of sample 
homogeneity. 
3.1. HISTORY OF ANTI-DOPING 
The word doping is probably derived from the Dutch word dop, the name of an alcoholic 
beverage made of grape skins used by Zulu warriors in order to enhance their prowess in battle. 
The term became current around the 20th century. The practice of enhancing performance 
through foreign substance or other artificial means, however, is as old as competitive sport 
itself. 
In 1928 the IAAF (International Association of Athletics Federations) became the first 
International Sport Federation (IF) to ban doping, the use of stimulating substances. Many other 
International Sport Federations followed suit, but restrictions remained ineffective as no tests 
were performed. 
The death of Knud Enemark Jensen (Danish cyclist) during competition at the Olympic 
Games in Rome in 1960 increased the pressure for sports authorities to introduce drug test, due 
to the autopsy revealed traces of amphetamine. 
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In 1966 Union Cycliste Internationale (UCI) and Fédération Internationales de Football 
Association (FIFA) were among the first IFs to introduce doping tests in their respective World 
Champions. In the next year the International Olympic Committee (IOC) instituted its Medical 
Commission and set up its first list of prohibited substances[1]. 
3.1.1. Doping 
Doping in general is defined as the use of substances or forbidden methods in the sport. 
However, since the introduction of the international code of WADA, the concept is applied as the 
occurrence of one or more of the anti-doping rule violations. 
WADA defines doping as the fact of violate any of these anti-doping rules[3]:  
1. Presence of a prohibited substance or its metabolites or markers in an athlete’s 
sample. 
2. Use or attempted use by an athlete of a prohibited substance or a prohibited 
method. 
3. Evading, refusing or failing to submit sample collection. 
4. Whereabouts failures. 
5. Tampering or attempted tampering with any part of doping control. 
6. Possession of a prohibited substance or a prohibited method. 
7. Trafficking or attempted trafficking in any prohibited substance or prohibited 
method. 
8. Administration or attempt administration to any athlete in-competition of any 
prohibited substance or prohibited method, or administration or attempted 
administration to any athlete out-of-competition of any prohibited substance or any 
prohibited method that is prohibited out-of-competition. 
9. Complicity. 
10. Prohibited association. 
Doping substances can be classified in different groups; some of them are listed below (see 
Table 1): 
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Steroids 
Substances that influencing the production of amino acids, contribute to 
increase muscle mass, strength and aggressiveness. 
Stimulants Substances are used to be more awake and to delay the fatigue. 
Narcotic analgesic Substances that relieve pain and get a calming effect. 
Beta blockers Substances that decrease the heartbeat. 
Diuretics Substances used to lose weight quickly. 
Table 1.Different groups of substances. 
3.2. WORLD ANTI-DOPING AGENCY 
The WADA was established in 1999 as an international independent agency composed and 
funded equally by the sport movement and governments of the world. Its key activities include 
scientific research, education, development of anti-doping capacities, and monitoring of the 
World Anti Doping Code- the document harmonizing anti-doping policies in all sports and all 
countries[1]. 
WADA works towards a vision of a world where all athletes compete in a doping-free 
sporting environment. 
The First World Conference on Doping in Sport held, in Lausanne, on 1999, produced the 
Lausanne Declaration on Doping in Sport. This document provided the basis for the creation of 
an independent international anti-doping agency to be operational for the Games of the XXVII 
Olympiad in Sydney in 2000. 
Pursuant to the terms of the Lausanne Declaration, the World Anti-Doping Agency( WADA) 
was established on November, 1999, in Lausanne to promote and coordinate the fight against 
doping in sport internationally[1]. 
WADA publishes the prohibited list every year, where the prohibited substances in- and out-
of-competition and in particular sports are listed along with the prohibited methods too. The 
2015 prohibited list[4] of substances is shown below in a summary table (see Table 2). 
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 Substances prohibited in- and out-of-competition 
Anabolic agents 
Peptide hormones, growth factors, related substances and mimetics 
Beta-2 agonists 
Hormone and metabolic modulators 
Diuretics and masking agents 
 Substances prohibited in-competition 
Stimulants 
Narcotics 
Cannabinoids 
Glucocorticoids 
 Substances prohibited in particular sports 
Alcohol 
Beta-blockers 
Table 2.The 2015 list of prohibited substances. 
3.3. THE ANALYTICAL TASK OF AN ANTI-DOPING LABORATORY 
IMIM laboratory receives and analyzes different types of matrixes. The most common are 
urine and blood, from both humans and horses. 
The laboratory is usually receiving two individual subsamples of each analysis to be 
performed, which are independently sealed (A and B). The authorized personal carry out the 
reception of the samples and assigned the intern code of the laboratory to all them.  
If the sample is an athlete’s sample, the subsample A is kept sealed in a cold chamber. The 
sample B is also kept sealed, in a freezer as potential counter-analysis sample.  
As soon as possible, the subsample A is inspected. The internal code and the internal 
information are revised, and some visual characteristics of the sample are registered. Then the 
subsample is divided in aliquots. Every aliquot will be subjected to a screening analysis of some 
family or families of substances. 
If the result is negative for all the screening procedures, the report of results will be emitted. 
If the sample is presumably positive to some substances, a new aliquot of the subsample A will 
be distributed to carry out a specific confirmation procedure. The person responsible has to 
decide if these results are definitive or if it is necessary to apply new confirmation procedures. 
When the results are considered definitive, the report of results is sent to the appropriate 
sports authority which can request the analysis of the subsample B (counter-analysis). Figure 1 
is summarising the process. 
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Figure 1. Scheme summarising the process of the reception of samples 
The participation in interlaboratory comparisons and the regular use of reference material 
are two of the requirements of testing laboratories to assure the quality of analytical results 
according to international quality standards such as ISO 17025. IMIM is coordinator of 
interlaboratory comparison. IMIM prepare reference materials and it has a control of the quality 
of the analytical results of the laboratory as every anti-doping laboratory. In some exercise of 
interlaboratory comparison some problems of instability were detected by IMIM. 
During the transport, the reception and the analysis of samples can pass a large period of 
time. Some irregularities can occur and affect samples. To minimize this and to have control of 
what can happen to samples during this process, some studies have been carried out for some 
laboratories to ascertain the stability of various samples in different condition[5]–[14]. Some 
conditions as for example the storage temperature, the type of containers and studies that 
simulate the situation of the transport and distribution of the sample have been described in the 
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literature. For example, the sample is stored at -20ºC, and then is 3 days at room temperature, 
and then is frozen again. 
All these studies are so important in anti-doping control mainly because the presence of 
prohibited substances in these matrices may involve legal consequences for individuals. In anti-
doping control it is also important to ensure that analyte instability will not affect the analytical 
results during the retesting period[14].   
3.4. REFERENCE MATERIALS 
3.4.1. Introduction 
The growing importance of chemical measurements in modern society has rendered 
urgently the development of measures to improve the quality of analytical results and to 
guarantee their quality to the end users. 
The objective of the chemicals analysis is to provide information on the composition of 
materials. If neither losses of information nor increase of the content are achieved, the result 
can be compared to other results obtained with the same guarantee of quality. 
In all analyses, the analyst has to demonstrate the quality of his result and that it leads to 
reliable- traceable-results. The only way to achieve this demonstration is to compare the result 
to the value assigned to a known material. Such a material is called a “Reference Material” 
(RM). 
Reference Materials allow the comparison of a real sample to a known material for the 
identification and the quantification of the substance of interest. Reference materials are used in 
interlaboratory studies (such as proficiency testing schemes, PTS) or statistical control schemes 
(control charts). 
A reference material, according to the guide ISO 30:2015, is a material sufficiently 
homogeneous and stable with respect to one or more specified properties, which has been 
established to be fit for its intended use in a measurement process. 
When the property values are certified by a procedure that establishes its traceability to an 
accurate value with its uncertainty, it becomes a Certified Reference Material (CRM). The use of 
certified reference material is the easiest way to demonstrate accuracy and to verify the 
performance of the laboratory at any desired moment. 
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A certified reference material, according to the guide ISO 30:2015, is a reference material 
characterized by a metrologically valid procedure for one or more specified properties, 
accompanied by a reference material certificate that provides the value of the specified 
property, its associated uncertainty, and a statement of metrological traceability. 
So that a material was considered as a certified reference material, it has to accomplish 
some properties[15]. The most important are: 
 Traceability 
 Homogeneity 
 Stability 
 Similarity with the real samples 
 Uncertainty 
Besides the requirement to use Certified Reference Materials (CRMs) to verify the accuracy 
of their measurements and validate their methods, accredited laboratories have to monitor the 
long-term performance of their analytical methods by using non-certified Reference Materials, 
that is Quality Control Materials (QCMs) . 
3.4.2. Methods and tools for reference materials production[16] 
For liquid reference materials the handling during production may be subjected to specific 
problems, such as contamination, evaporation, or leakage. Particles suspended in the liquid will 
increase the inhomogeneity, and filtration should be applied. 
Some issues that are important to produce a reference material are listed below: 
 Contamination control: the purpose of any material is that the compounds of 
interest, the analytes, are present in about the same concentration range as in the 
sample that is analyzed in a routine operation. In reference material production, the 
procedures should be established to prevent or at least minimize contamination. 
 Bulk sampling: the mass of the bulk material depends on the required number of 
units, losses during processing and losses during bottling. 
 Pretreatment for the handling of liquids: 
o Pretreatment: it is important to have controlled the temperature to minimize 
degradation of organic or organo-metallic compounds. Oxidation of the 
matrix or analyte can create a problem, forcing operation and storage to be 
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carried out under a protective atmosphere when necessary. For similar 
reasons the liquids should be kept out of direct sun light, minimizing photo-
oxidation. 
o Filtration: Suspended particles most probably have typical different contents 
of analyte, and as a consequence they are a serious source of 
inhomogeneity. Therefore, when liquid contain particulate matter they are 
best filtered before homogenization. 
o Homogenisation: Mechanical stirring is a first option. Mixing time should be 
the main parameter. Purging by nitrogen or argon can be also a way of 
homogenization. 
o Containers: liquid reference materials can be contained in bottles or vials. 
They can be made of glass, quartz or artificial material. Various types of 
stoppers are available. The most common types are made of rubber with or 
without a thin Teflon layer. 
o Bottling of liquids: The first litres from the system are discarded, as they are 
used to clean the pump and tubing system. 
o Labelling: the text on the label of reference material should indicate the 
name of the product, a reference material name or number and an individual 
sample identification number. It should give information on the composition 
and purpose. 
o Transport and storage: Depending on the expected stability of the material 
or the analyte, the reference material has to be stored under the appropriate 
conditions. For example, temperature, humidity and light should be 
controlled, if necessary. 
3.4.3. Testing[16] 
In order to assess the main properties of a candidate reference material, there are different 
properties to be tested. The most important are explained below. 
3.4.3.1. Homogeneity testing 
After the bottling has been completed, the units should be tested for the homogeneous 
distribution of the analytes, also called the specific homogeneity, both for between units and 
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within units. For reference materials that are produced to be used in total, so called “single 
shot”, only the between-unit homogeneity is tested. 
Nearly every material is at least to some extent inhomogeneous. It is therefore necessary to 
check (using a reasonable number of samples) if the differences between units stay within 
acceptable limits. The method must be selected for its repeatability (precision), not its trueness 
(accuracy, absence of bias). If it is possible, all samples are to be measured on the same day, 
with the same instrument, by the same operator, against the same calibrants, that is under 
repeatability conditions. 
If the material is not prepared in portions for single use but in larger units from which test 
portions are to be taken, it is necessary to check if all sub-samples from one unit are identical in 
terms of the properties of interest. 
To evaluate the homogeneity, an F-test comparing variances of between and within units 
(random error) is performed. 
FCALC. >1,     FCALC. = 
𝑆2𝑆𝑇𝑈𝐷𝐼𝐸𝐷  𝐹𝐴𝐶𝑇𝑂𝑅
𝑆2𝑅𝐴𝑁𝐷𝑂𝑀  𝐸𝑅𝑅𝑂𝑅
 
The material will be considered homogeneous when FCALC. < FCRIT. .Where FCRIT. is a 
tabulated value. 
Another criterion that can be applied to evaluate the homogeneity is the precision Model of 
Horwitz. This model indicates that the standard deviation of a model varies with the 
concentration according to the following equation: 
RSD= 2(1−0,5·𝑙𝑜𝑔𝑐 ) 
sHORWITZ is obtained applying the relative standard deviation (RSD) obtained with the 
average value of the concentration. 
sHORWITZ = ( 𝑅𝑆𝐷 ∗ 2 ∗ 𝐶 ) 100  
sSAMPLE is obtained applying the following equations using the values obtained in the 
ANOVA test: 
s2SAMPLE = 
𝑠2𝐵𝐸𝑇𝑊𝐸𝐸𝑁− 𝑆2𝑊𝐼𝑇𝐻𝐼𝑁
𝑁º 𝑅𝐸𝑃𝐿𝐼𝐶𝐴𝑇𝐸𝐷
 
 
sSAMPLE = 𝑆𝑆𝐴𝑀𝑃𝐿𝐸
2  
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Finally, the material will be considered homogeneous when 𝑆𝑆𝐴𝑀𝑃𝐿𝐸 𝑆𝐻𝑂𝑅𝑊𝐼𝑇𝑍  < 0,3 
according to The international harmonized protocol for the proficiency testing of analytical 
chemistry laboratories. This condition is called “sufficient homogeneity”. 
3.4.3.2. Stability testing 
The most common approach to stability testing is to expose the reference material to 
conditions that are likely to lead the degradation or transformation of the analyte. 
For stability testing, a sufficiently large selection of bottles is stored under conditions that are 
expected to accelerate any process of modification or degradation. Assuming now the 
deteriorating cause is the temperature (as in most cases), samples are stored in parallel at: 
 The normal storage temperature 
 An elevated temperature (to speed up deterioration processes, and to mimic 
transport conditions that are less well under control) 
 At a temperature where no changes are expected, the so called “safe 
temperature” 
Stability is evaluated by analyzing samples, stored at different condition, as a function of 
time. The time steps will highly depend on the intended use. Independent analyses are carried 
out in triplicate for each storage time and temperature.  
The measurement method to be applied for the purpose of stability testing should be one 
with the best available long-term reproducibility.  For example, all aliquots of the sample are 
stored at different conditions of temperature as 4 ºC, -20 ºC. For the t= 3 month result, sample 
stored at 20 ºC and sample stored at 4 ºC are analyzed. For the t=6 months the same routine is 
performed. This routine can be performed at 0, 3, 6, 12, 24 and 36 months for example. This 
method can be applied for different conditions of samples as for example samples stored at 4 
ºC, lyophilized samples stored at 4 ºC, samples stored at different temperatures (stored 2 
months at 4 ºC, then stored 3 days at room temperature...). 
Samples stored at -20ºC act as reference for the samples stored at different temperatures.  
The evaluation makes use of the ratio, which is based on the value of 3 determinations 
made after storage at elevated temperature, divided by the mean value for 3 measurements of 
samples stored at the safe temperature. 
Preparation of reference materials for anti-doping control: study of the lyophilisation conditions.  17 
 
If some changes occur at the safe temperature, the material is not be considered stable. On 
the other hand, if small changes occur at refrigerator temperatures and significant changes at 
ambient temperature, it is certain that the reference material will need storage in a freezer, and 
probably require cooled transport. Finally, if no changes occur at any of these conditions, the 
material will be considered stable during the self-life of the material. 
Some literature about the preparation of reference materials of lyophilized urine samples 
have been consulted[14], [17], [18]. In these literatures studies of stability during a large period 
of time, and studies of homogeneity were performed to the preparation of the different reference 
materials. Conditions of lyophilisation used in literature [14] and [17] were similar in the pressure 
used and in the temperature reached by the apparatus. 
Literature about protocols for stability and homogeneity studies of drugs for its application to 
doping control has been consulted[13]. In this literature, different protocols were performed 
which were protocols to study the adsorption of analytes on sterilizing filters, protocols for 
homogeneity testing and protocols for stability testing. Long-term stability and short-term 
stability was evaluated in liquid urine stored at different temperatures. Homogeneity was tested 
with a minimum of 5 aliquots. 
3.5. LYOPHILISATION 
Freeze-drying, also referred to as lyophilisation, is the process of removing water from a 
sample by sublimation and desorption[14]. That is to say that lyophilisation is a dehydration 
process of samples at low pressure, vacuum, and moderated temperature. In this process, the 
evaporation of water is produced by the sublimation of the ice. For this reason, the samples 
have must be solidified during the drying[19]. 
This procedure involves a minimum alteration of the molecular structure of the sample so 
urine should not be affected by changes in temperature and should ensure its stability[14]. The 
samples keep all their original characteristics. 
The process of lyophilisation is divided in two stages, freezing and drying. The freezing of 
the samples is the most important step because it may interferes in the appearance and the 
properties of the final product. 
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If the freezing is slow, water will create big ice crystals. These crystals will produce open 
structures after the drying. On the other hand, if the freezing is quickly, water will create small 
crystals. These crystals will make difficult the escape of water vapour[20]. 
The principal methods to perform freezing are: 
 Refrigeration by direct contact of the sample with a surface or environment cooled. 
 Rotational refrigeration in a bath. 
o Spin freezer 
o Shell freezing 
The size of the crystals during the solidification will define the appearance and a lot of 
properties of the final product. Products solidified quickly will have a lightly colouring compared 
with a product solidified slowly. Also, some properties as concentration and viscosity of the 
product will influence in the entire process. 
Sometimes the cooled product presents a deceptive appearance looking like the 
solidification is completely, but when it is subjected at the vacuum, it foam. 
During drying, sublimation is an important step. Sublimation depends of some factors as for 
example the thickness of the cooled product, thermal conductivity, the composition of the 
product, etc. 
Sublimation is the physic process where the substance goes from solid to vapour. For the 
production of this process is important to control the pressure and the temperature. 
In the technique of lyophilisation, the drying is divided in two steps: 
 Primary dry: ice is sublimated. 
 Secondary dry: residual moisture is removed from the sample. 
At the beginning of the drying, the sublimation succeeds at the surface of the cooled 
sample, and then continues along the depth of the sample. The vapours will have to migrate 
through the dry product. 
At secondary step, water confined by absorption is removed. It is possible, if necessary, to 
accelerate the process, heating the trays of the instrument. 
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THCCOOH Benzoylecgonine 
Ethanol 
Ethyl Glucuronide 
Ethyl Sulfate 
3.6. ANALYTES  
In this project different analytes will be analysed. Briefly, some information about every 
analyte will be explained below. 
Both, studies of homogeneity and quantification of analytes of the samples, used 
quantification procedures that include hydrolysis, extraction solid-liquid, analysis by gas 
chromatography coupled with mass spectrometry (GC/MS) and analysis by liquid 
chromatography coupled with tandem mass spectrometry (LC/MS-MS). 
The structures of the studied analytes are shown in Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Structure of the studied analytes. 
3.6.1. Ethanol, Ethyl glucuronide and Ethyl sulphate 
Briefly, ethanol is a volatile, flammable, colourless liquid with a strong chemical odour. Its 
structural formula is CH3CH2OH. 
TH -COOH 
Ethanol 
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Alcohol is a central nervous system depressant that slows down the actions of brain and 
body. The purpose of alcohol abuse is the reduction of anxiety, reduction of tremor and 
relaxation. Consequently alcohol is abused in sports needing high concentration[21]. 
Ethanol is an exogenous substance mentioned in the Prohibited list of WADA from 2015. 
Alcohol is prohibited in-competition only, in the following sports: air sports (FAI), archery (WA), 
automobile (FIA), motorcycling (FIM) and powerboarting (UIM)[4]. 
On one hand, ethyl glucuronide (EtG) is a direct metabolite of ethanol. Its presence in urine 
may be used to detect recent ethanol ingestion, even after ethanol is no longer measurable. The 
presence of this metabolite in urine is an indicator that alcohol was ingested.  
On the other hand, in addition to EtG some scientific studies have identified ethyl sulphate 
(EtS) as a second specific metabolite or biomarker of ethanol. 
The detection of both metabolites offers greater sensitivity and accuracy for determination of 
recent alcohol ingestion, than by detection of either biomarker alone. 
The presence of EtG and EtS in urine indicates that ethanol was ingested within the 
previous 3 to 4 days, or approximately 80 hours after alcohol has been ingested. 
3.6.2. Benzoylecgonine 
Benzoylecgonine (BE) is the main metabolite of cocaine.  When a person takes cocaine 
(chemically benzoylmethylecgonine), it gets metabolized in the liver to form benzoylecgonine. 
The metabolite is then excreted out of the body via urine[22]. 
Cocaine is a substance mentioned in the Prohibited list of WADA from 2015. Cocaine is 
prohibited in-competition. It is a non- specific stimulant. 
3.6.3. 11- nor- Δ9- tetrahydrocannabinol- 9- carboxylic acid 
Cannabis continues to be the most widely used illicit drug in many countries around the 
world. Δ9- tetrahydrocannabinol (THC), the major psychoactive component of cannabis, is 
rapidly metabolized to the inactive metabolite THC-COOH, conjugated with glucuronic acid, and 
excreted in urine[23]. 
THC is a substance mentioned in the Prohibited list of WADA from 2015. Cannabinoids are 
prohibited in-competition. 
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4. OBJECTIVES 
The main objective of this project is try to solve some problems detected in various fresh 
urine samples used for the interlaboratory comparison by IMIM. Degradations in reference 
materials of 11- nor- Δ9- tetrahydrocannabinol- 9- carboxylic acid (THC-COOH) and 
Benzoylecgonine (BE) prepared by IMIM (coordinator of interlaboratory comparison) were 
detected in passed assays. These samples were analyzed approximately 2 months after their 
production and these degradations were observed. For this reason reference materials of 11- 
nor- Δ9- tetrahydrocannabinol- 9- carboxylic acid (THCCOOH), benzoylecgonine (BE), ethanol 
(EtOH) and ethyl glucuronide (EtG) and ethyl sulphate (EtS) will be prepared to study the 
conditions of lyophilisation as a solution for extending the shelf life and ensuring the stability of 
the drug and realise if during the process some loss of any of the analytes could exists.  
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5. EXPERIMENTAL SECTION 
5.1. APPARATUS AND INSTRUMENTS 
 Gas chromatography coupled with mass spectrometry: an Agilent 6890N series GC 
system equipped with a quadrupole MS (Agilent 5973N mass selective detector) and 
autosampler (Agilent 7683 series injector). 
 Liquid chromatography coupled with tandem mass spectrometry: an Acquity UPLC 
system (Waters Corporation) equipped with a triple quadrupole (XEVO TQMS) mass 
spectrometer equipped with an orthogonal Z-spray-electrospray ionization source 
(ESI) (all from Waters-Corporation, Milford, MA, USA). 
 Lyophilizer: Model lioalfa-6 (Telstar) 
 Evaporator: Turbovap LV Evaporator (Zymark) 
 Ph meter: Model GLP21 (Crison) 
 Refractometer: Palette Digital refractometer (ATAGO) 
 Analytical balance: Model XS205D4 (Mettler Toledo) 
 Vacuum oven: Gallenkamp 
 Dry bath: Multiplaces (Selecta) 
5.2. STANDARD SOLUTIONS 
The standard solution of EtG 1 mg/mL, EtS 1 mg/mL and the mixed standard solution of 
Ethyl glucuronide-d5 10 µg/mL and ethyl sulphate-d5 10 µg/mL were prepared using methanol 
as a solvent. 
The standard solution of BE 1 mg/mL was prepared in water. The standard solution of 
benzoylecgonine-d3 10 µg/mL was prepared using methanol as a solvent. 
The standard solution of THC-COOH 100 µg/mL and the standard solution of THC-COOH-
d3 1 µg/mL were prepared using methanol as a solvent.  
5.3. PRELIMINARY TESTS FOR ESTABLISHING LYOPHILISING CONDITIONS 
Different tests were performed to decide the most suitable lyophilisation conditions and the 
best container and volume of urine to lyophilize the samples without losses of sample. Three 
different containers were used during the tests (see Figure 3). 
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Figure 3. Different containers used during the tests. The symbol ᴓ is referred to the diameter of the top of 
the bottle. 
Five tests were carried out.  
In the first test, three different bottles were filled with water and with blank urine. Bottles with 
a capacity of 30 mL and 50 mL were filled with 20 mL. Bottles with a capacity of 10 mL were 
filled with 5 mL. The purpose of this test was to check if the freeze- drier worked properly with 
this type of matrix as only solid samples were used beforehand. 
In second test, bottles were filled with different volumes of blank urine and Milli Q water. 
Bottles with a capacity of 30 mL and 50 mL were filled with 5 mL, 10 mL, 15 mL and 20 mL. 
Bottles with a capacity of 10 mL were filled with 2 mL and 5 mL. The purpose of this test was to 
check the maximum volume advisable to fill the bottles and to assure no losses of sample 
during the process. 
In third test, bottles were filled with treated blank urine and untreated blank urine. Bottles 
with a capacity of 30 mL were filled with 5 mL and 10 mL. Bottles with a capacity of 10 mL were 
filled with 2 mL and 5 mL. Also a tray of the instrument was filled with 80 mL of treated blank 
urine. The purpose of this test was to check if any substance in the urine could influence in the 
correct lyophilisation of the samples. 
(a) (b) (c) 
Topaz bottle with a capacity 
of 10 mL 
ᴓ 20 mm 
Topaz bottle with a capacity 
of 30 mL 
ᴓ 30 mm 
Transparent bottle with a 
capacity of 50 mL 
ᴓ 20 mm 
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In fourth test, bottles were filled with three different dilutions of blank urine with water. The 
dilutions were 50 %, 25 % and 12,5 %. Bottles with a capacity of 30 mL and 50 mL were filled 
with 5 mL and 10 mL. Bottles with a capacity of 10 mL were filled with 1 mL, 2 mL and 5 mL. 
The purpose of this test was to check if the dilution factor of the blank urine could have an effect 
on the lyophilisation process. 
Finally, in fifth test, bottles were filled with two dilutions of blank urine with water. The 
dilution were 25 % and 12,5 %. Bottles with a capacity of 50 mL were filled with 15 mL, 20 mL 
and 25 mL. The purpose of this test was to check if higher dilution factors allowed working with 
higher volumes without losses. 
Different combinations of bottling tests are listed in Table 3. 
 
Test Type of bottle Volume and matrix 
Nº bottles 
tested 
1 
Topaz bottle 
(10 mL)      ᴓ≈ 20 mm 
5 mL Milli Q water  5 
5 mL blank urine  5 
Topaz bottle 
(30 mL)      ᴓ≈ 30 mm 
20 mL Milli Q water  5 
20 mL blank urine  5 
Transparent bottle 
(50 mL)      ᴓ≈ 20 mm 
20 mL Milli Q water  5 
20 mL blank urine  5 
2 
Topaz bottle 
(10 mL)      ᴓ≈ 20 mm 
2 mL Milli Q water  1 
2 mL blank urine  2 
5 mL Milli Q water  1 
5 mL blank urine  2 
Topaz bottle 
(30 mL)      ᴓ≈ 30 mm 
5 mL blank urine  2 
10 mL blank urine  2 
15 mL Milli Q water  1 
15 mL blank urine  2 
20 mL Milli Q water  1 
20 mL blank urine  2 
Transparent bottle 
(50 mL)      ᴓ≈ 20 mm 
5 mL blank urine  2 
10 mL blank urine  2 
15 mL Milli Q water  1 
15 mL blank urine  2 
20 mL Milli Q water  1 
20 mL blank urine  2 
Table 3.Summary table of preliminary tests for establishing lyophilising conditions. 
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Test Type of bottle Volume and matrix 
Nº bottles 
tested 
3 
Topaz bottle 
(10 mL)      ᴓ≈ 20 mm 
2 mL blank urine 2 
2 mL untreated blank urine 2 
5 mL blank urine 2 
5 mL untreated blank urine 2 
Topaz bottle 
(30 mL)      ᴓ≈ 30 mm 
5 mL blank urine 2 
5 mL untreated blank urine 2 
10 mL blank urine 2 
10 mL untreated blank urine 2 
Tray 80 mL blank urine 1 
4 
These combinations with blank urine diluted 50%, 25% and 12,5% 
Topaz bottle 
(10 mL)      ᴓ≈ 20 mm 
1 mL blank urine 2 
2 mL blank urine 2 
5 mL blank urine 2 
Topaz bottle 
(30 mL)      ᴓ≈ 30 mm 
5 mL blank urine 2 
10 mL blank urine 2 
Transparent bottle 
(50 mL)      ᴓ≈ 20 mm 
5 mL blank urine 2 
10 mL blank urine 2 
5 
These combinations with blank urine diluted 25% and 12,5% 
Transparent bottle 
(50 mL)      ᴓ≈ 20 mm 
15 mL blank urine 2 
20 mL blank urine 2 
25 mL blank urine 2 
Table 3 (cont.).Summary table of preliminary tests for establishing lyophilising conditions. 
5.4. ANALYTICAL METHOD 
A scheme summarising all the steps performed during the analytical method is shown in 
Figure 4. 
5.4.1. Preparation of samples for study of lyophilisation conditions 
5.4.1.1. Preparation of blank urine 
Two litres of blank urine collected from a healthy volunteer were used to prepare the 
samples. Blank urine was analyzed to verify the absence of interfering compounds. If any 
prohibited substance was detected, the blank urine will be rejected. 
Urine was stabilized with sodium azide 0,1 % w/v. A volume of urine was adjusted to pH 
5,50 with HCl to prepare the samples of ethanol, ethyl glucuronide, ethyl sulphate and 
benzoylecgonine. Some studies[12][9] demonstrate that BE is more stable at pH 5. However, 
studies demonstrate that THC-COOH is more stable at pH 7. 
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On the other hand a separate volume was adjusted to pH 6,96 to prepare the sample of 
THCCOOH. This volume of urine was adjusted with KOH 6M from blank urine with pH 5,50. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Scheme summarising the process of the analytical method. 
Then the urine was clarified by filtration using three different filters (one cellulose reinforced 
disc membrane filter and two glass fiber filters of different pore size). Firsts 200 mL were 
rejected (see Figure 5). 
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Figure 5. Filtration of blank urine. 
5.4.1.2. Preparation of urine samples 
Once blank urine was filtered, bulk urine sample were diluted down to 12,5 % with double 
deionised water and all the samples were spiked with the adequate volumes of the standard 
solution of the drug to result in the target concentration listed in Table 4 by using an automatic 
pipette. These target concentrations were chosen to prepare positive samples taking into 
account the limit concentration imposed by WADA. Spiking volumes of standard solutions were 
from 500 µL to 2,5 mL according to the concentration of stock standard solution (see Table 4). 
The adequate volume of the standard solution of THC-COOH was necessary to evaporate 
in an evaporator at 17 ºC and with a nitrogen pressure minor of 10 psi due to the standard 
solution was prepared with methanol as a solvent. Then, it was reconstituted with blank urine 
until the entire product was pulled. 
The measured values for specific gravity and pH of the samples are listed in Table 5.  
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Sample Compound 
Target 
concentration 
[mg/L] 
Volume of 
sample 
[mL] 
Concentration 
of standard 
solutions 
Spiked 
volume 
[µL] 
Sample 1 THC-COOH 0,3 800 100 µg/mL 2400 
Sample 2 BE 1,5 800 1 mg/mL 1500 
Sample 3 EtOH 4000 100 - 505 
Sample 4 EtG/EtS 10  100 1 mg/mL 1000 
Table 4.Composition of the sample, target concentrations, total volume of the sample, concentration of 
standard solutions and spiked volumes. 
 
Sample Compound pH Specific gravity 
Sample 1 THC-COOH 6,96 1,0014 
Sample 2 BE 5,50 1,0014 
Sample 3 EtOH 5,50 1,0022 
Sample 4 EtG/EtS 5,50 1,0024 
Table 5. pH values and specific gravity of the samples. 
5.4.1.3. Preparation of aliquots  
First of all, the laminar flow cabinet was prepared. All the needed material was introduced in 
the cabinet: samples, the pump, sterile bottles, sterile stoppers, a Bunsen burner, two beakers, 
a pair of sterile gloves, an sterile filter, a pipette, a stand and another pipette to shake the 
sample during the process. 
The laminar flow cabinet was closed and the Ultraviolet (UV) light was switched on for at 
least 30 minutes. Then, the light and flow of the cabined were switched on, and the UV was 
turned off. 
The assembly was prepared and the sterile filter was connected to the pump. Sample 1 and 
2 were shaking and samples were completely filtered under sterile conditions to an intermediate 
bulk (beaker) after discarding 150 mL (dead volume). 
After all the sample was completely filtered, 15 mL of the sample were pipette in transparent 
bottles (see Figure 3c). A total of 36 bottles were prepared.  
Just after filling, every bottle was approached to the Bunsen burner to sterilize it before 
capping the bottle with a stopper. 
Preparation of reference materials for anti-doping control: study of the lyophilisation conditions.  29 
 
Different aliquots of sample, covering all the bottling process (1, 2, 9, 10, 27, 28, 35, 36), 
were separated to the rest. These aliquots were used to test the homogeneity of the sample. 
     Differently from samples 1 and 2, urine samples 3 and 4 were only filtered before being 
spiked due to dead volume would have been bigger than the volume needed of the samples. 
These samples were pipette without sterile conditions. 2 mL of the sample were pipette in topaz 
bottles (see Figure 3a). A total of 36 bottles were prepared of every sample. 
Different aliquots were stored at different conditions to be analyzed at 0, 3, 6, 12, 24 and 36 
months to a future study of stability. 
5.4.1.4. Lyophilisation process 
The lyophilisation process of the samples was carried out at Mat Control Laboratory of 
Analytical Chemistry Department (UB). 
The conditions of lyophilisation used were the following. First of all, the aliquots were frozen at -
20 ºC at least overnight. Then, the samples were introduced into the apparatus. First, the 
temperature of the freeze-dryer reached -31 ºC and then the vacuum pump was turned on and 
the pressure of the freeze-dryer was reduced until 0,07 mBa. This succeeds while the 
temperature of the apparatus was achieving -41 ºC. The final conditions of lyophilisation were a 
temperature of -46 ºC or less, a pressure of 0,07 mBa and the process succeed during at least 
24 hours (see Figure 6). 
                                                ≈15 min    
              
                                 T=          -31 ºC          -41 ºC          -46 ºC 
                              
                                                                      P=          0,07 mBa 
                                   Time: 24 hours. 
Figure 6. Lyophilisation process 
5.4.1.5. Storage conditions 
Lyophilized aliquots and fresh aliquots were stored at 4 ºC until analysis. Reference aliquots 
were stored at -20 ºC until analysis. 
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5.4.2. Quantification of THC-COOH 
Fresh, lyophilized and reference samples were quantified in two different batches with two 
different groups of calibration tubes. 
Lyophilized aliquots were first reconstituted with 15 mL of Milli Q water. Then, aliquots were 
mixed slowly after adding water, 5 minutes later samples were diluted mixing by inversion until 
complete dissolution. 
In each batch of analysis, blank urines, samples under study and control urine samples 
were analyzed. Sample volumes analyzed were 3 mL in all cases. Samples under study were 
diluted by half (volume) with blank urine due to its target concentration wasn’t into the 
concentration range of the calibration tubes. 
For calibration, the suitable volume of standard was place in the calibration tubes to cover a 
concentration range of 50, 100, 150, 200 and 300 ng/mL. 
50 µL of the standard solution of THC-COOH-d3 1 µg/mL were added to all tubes as 
internal standard. 
Hydrolysis was performed by adding 300 µL of KOH 10M in all the tubes, mixing with a 
vortex and introducing all the tubes in a dry-bath 15 minutes at 61 ºC. 
400 µL of glacial acetic acid and 3 mL of phosphoric acid 50mM were added in the tubes to 
adjust the pH to 4-5. Then, tubes were centrifuged at least 5 minutes at 2500 rpm. 
Bond-Elut Certify columns were conditioned by washing with 2 mL of methanol and 2 mL of 
phosphoric acid 50 mM. The columns were prevented from drying. After adding the urine 
samples, columns were washed with 9 mL of phosphoric acid 50 mM and 3 mL of phosphoric 
acid 50 mM: methanol (80:20). The columns were dried at least 10 minutes. Then, 1 mL of 
hexane was added. Analytes were eluted with 2 mL of hexane: ethyl acetate (80:20). 
Eluates were evaporated to dryness under a nitrogen stream in a water bath at 48 ºC and 
immediately, kept it in a vacuum oven with diphosphorus pentoxide (T = 40 ± 5 ºC) for at least 1 
hour. Then, the derivatization was performed adding 50 µL of N- methyl- N- 
(trimethylsilyl)trifluoroacetamide (MSTFA):NH4I:2-Mercaptoethanol. The solution was mixed at 
least 30 seconds and kept it in a dry bath at least 30 minutes at 61 ºC. 
Finally, the solutions were transferred into the vials and injected into the chromatographic 
system. 
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The extracts were analyzed by gas chromatography coupled with mass spectrometry 
(GC/MS). Separation was performed using a methylsilicone capillary column (17 m x 0,2 mm id, 
0,11 µm film thickness, HP-ULTRA1). Helium was used as a carrier gas at a flow rate of 0,9-1,1 
mL/min. The oven was maintained at 200 ºC for 1 minute and the following rate was 
programmed: the temperature increased from 200 ºC to 280 ºC at 25 ºC/min, staying 2,8 
minutes at 280 ºC with a total run time of 7 minutes. Samples were injected in split mode. The 
volume injection was 1 µL .The injector and the interface temperature were set at 280 ºC. The 
MS was operated in electron impact ionization (70 eV) and in selected ion monitoring acquisition 
mode (SIM). Three ions were monitored for each substance and used as qualifying ions for their 
identification. The ions used for quantification were m/z 371 for THC-COOH-bis-TMS derivative 
and m/z 374 for THC-COOH-d3-bis-TMS derivative (see  Figure 7 and Table 6). 
 
 
THC-COOH-bis-TMS THC-COOH-d3-bis-TMS 
Figure 7. Product ions used for quantification of THC-COOH-bis-TMS and THC-COOH-d3-bis-TMS. 
Analyte RT [min] m/z 
THC-COOH-bis-TMS 4,3 ± 0,3 473, 371, 488 
THC-COOH-d3-bis-TMS 4,3 ± 0,3 476, 374, 491 
 
Table 6. Ions used for quantification of THC-COOH-bis-TMS and THC-COOH-d3-bis-TMS. 
 
371 374 
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5.4.3. Quantification of Benzoylecgonine 
Fresh, lyophilized and reference samples were quantified in two different batches with two 
different groups of calibration tubes. 
Lyophilized aliquots were first reconstituted with 15 mL of Milli Q water. Then, aliquots were 
mixed slowly after adding water, 5 minutes later samples were diluted mixing by inversion until 
complete dissolution. 
In each batch of analysis, blank urines, samples under study and control urine samples 
were analyzed. Sample volumes analyzed were 2 mL in all cases. 
For calibration, the suitable volume of standard was place in the calibration tubes to cover a 
concentration range of 100, 480, 1000, 1400 and 2000 ng/mL. 
50 µL of standard solution of benzoylecgonine-d3 10 µg/mL were added to all tubes as 
internal standard. 
1 mL of phosphate buffer 0,1 M pH7 was added in the tubes to adjust the pH to 7, and the 
result was mixed. Then, it was centrifuged at 2500 rpm. at least 5 minutes. 
Bond-Elut Certify columns were conditioned by washing with 2 mL of methanol and 2 mL of 
phosphate buffer 0,1 M pH7. The columns were prevented from drying. After adding the urine 
samples, columns were washed with 3 mL H2O Milli Q, 3 ml of HCl 0,1 M and 9 mL of methanol. 
The columns were dried at least 2 minutes. Then, analytes were eluted with 2 mL of 
CHCl3:iPrOH 80:20, NH3 2 %. 
Eluates were evaporated to dryness under a nitrogen stream in a water bath at 38 ºC and 
immediately, kept it in a vacuum oven with diphosphorus pentoxide (T = 40 ± 5 ºC) for at least 1 
hour. Then, the derivatization was performed adding 70 µL of Pentafluoropropionic anhydride 
(PFPA) and 30 µL of Hexafluoroisopropanol (HFIP). The solution was mixed and kept it in a 
dry-bath at least 10 minutes at 71 ºC. 
The extracts were evaporated to dryness under a nitrogen stream in a water bath at 38 ºC. 
Then, dried extracts were reconstituted in 50 µL of ethyl acetate. 
Finally, the solutions were transferred into the vials and injected into the chromatographic 
system. 
The extracts were analyzed by gas chromatography coupled with mass spectrometry 
(GC/MS). Separation was performed using a methylsilicone capillary column (16,5 m x 0,2 mm 
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id, 0,11 µm film thickness; HP-ULTRA1). Helium was used as a carrier gas at a flow rate of 0,9-
1,1 mL/min. Then the following rate was programmed: the temperature increased from 100 ºC 
to 280 ºC at 20 ºC/min, staying 4 minutes at 280 ºC with a total run time of 13 minutes. Samples 
were injected in split mode. The volume injection was 2 µL. The injector and the interface 
temperature were set at 280 ºC. The MS was operated in electron impact ionization (70 eV) and 
in selected ion monitoring acquisition mode (SIM). Three ions were monitored for each 
substance and used as qualifying ions for their identification. The ions used for quantification 
were m/z 318 for Benzoylecgonine-HFIP and m/z 321 for Benzoylecgonine-d3-HFIP (see Figure 
8 and Table 7). 
 
  
Benzoylecgonine-HFIP Benzoylecgonine-d3-HFIP 
Figure 8. Product ions used for quantification of Benzoylecgonine-HFIP and Benzoylecgonine-d3-HFIP. 
 
Analyte RT [min] m/z 
Benzoylecgonine-HFIP 6,15 ± 0,3 439, 318, 82 
Benzoylecgonine-d3-HFIP 6,17 ± 0,3 442, 321, 85 
 
Table 7. Ions used for quantification of Benzoylecgonine-HFIP and Benzoylecgonine-d3-HFIP. 
5.4.4. Quantification of Ethanol 
Quantification of ethanol was performed by Instituto Nacional de Toxicología y Ciencias 
Forenses Departamento de Barcelona. 
318 321 
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Fresh, lyophilized and reference samples were quantified in one batch. 
Lyophilized aliquots were first reconstituted with 2 mL of Milli Q water. Then, aliquots were 
mixed slowly after adding water, 5 minutes later samples were diluted mixing by inversion until 
complete dissolution. 
Briefly, to do the quantification of ethanol calibration samples and control samples were 
prepared.  
To prepare the samples, 100 µL of internal patron as for example n-propanol or tert-butileter 
were added in a vial, then 100 µL of the sample were added. A piece of paper was introduced 
into the vial and the vial was sealed. Then, the vial was introduced in an oven during a 
determinate time. 
Once the sample phase was introduced into the vial and the vial was sealed, volatile 
components diffused into the gas phase until the headspace had reached a state of equilibrium. 
The sample was then taken from the headspace. 
Then, a headspace GC analysis was performed. 
5.4.5. Quantification of Ethyl glucuronide and Ethyl sulphate 
Lyophilized aliquots were first reconstituted with 2 mL of Milli Q water. Then aliquots were 
mixed slowly after adding water, 5 minutes later samples were diluted mixing by inversion until 
complete dissolution. 
Fresh, lyophilized and reference samples were quantified in one batch. 
In each series of analysis, blank urines, samples under study and quality control urine 
samples were analyzed. Sample volumes analyzed were 50 µL in all cases. 
For calibration, the suitable volume of standard was place in the calibration vials to cover a 
concentration range of 5, 20, 50 and 100 µg/mL. 
50 µL of the mixed standard solution of Ethyl glucuronide-d5 10 µg/mL and ethyl sulphate-
d5 10 µg/mL were added to all vials. 
Finally, the solutions were mixed at least 10 seconds, and 900 µL of H2O with 0,1 % formic 
acid were added in all the vials. 
The extracts were analyzed by liquid chromatography coupled with tandem mass 
spectrometry (LC/MS-MS). 
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Chromatographic separations were carried out using an Acquity UPLC BEH C18 column 
(2,1 mm x 100 mm i.d., 1,7 µm particle size). The column temperature was set to 55 ºC. The 
mobile phase was a mixture of methanol and water with gradient elution. The initial methanol 
content (1,0 %) was maintained for 0,5 minutes and then increase to 90,0 % in 4,5 minutes, 
maintained there for 0,5 minutes, decreased to 1,0 % in 0,5 minutes and stabilized for 1,5 
minutes before the next injection. The flow rate of the mobile phase was maintained at 0,3 
mL/min. A total run time of 7,5 minutes. The volume injection was 10 µL. 
Drying gas as well as nebulising gas was nitrogen. The desolvation gas flow was set to 
1200 L/h, and the cone gas flow was 50 L/h. The nitrogen desolvation temperature was 450 ºC, 
and the source temperature was 120 ºC. 
The mass spectrometric conditions of the selected reaction monitoring (SRM) method are 
described in Table 8. Product ions used to quantify samples are in bold in Table 8. 
 
Compound Mode RT [min] 
Precursor Ion 
(m/z) 
Product Ion (m/z) CV [V] CE [eV] 
EtS NEG 1,19 125 [M-H]- 97, 80 20 10 
EtS-d5 NEG 1,17 130 [M-H]- 98 20 10 
EtG POS 1,44 240 [M+ NH4+]+ 141, 159, 205 10 10 
EtG-d5 POS 1,47 245 [M+NH4+]+ 141, 159, 210 10 10 
Table 8. Mass spectrometric conditions of the SRM method. 
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6. DISCUSSIONS AND RESULTS  
6.1. PRELIMINARY TESTS FOR ESTABLISHING LYOPHILISING CONDITIONS 
Different tests were carried out to choose the most suitable conditions and the best 
container and volume to lyophilize the samples without losses. 
The first test demonstrated that the apparatus worked properly with urine samples. The time 
chosen to lyophilize the samples was not enough with 16 hours (Figure 9), therefore it was 
decided to lyophilize samples during at least 24 hours in the next tests to assure a completely 
lyophilisation. 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Results obtained for Test 1. 
Trying to correct the loss of samples (Figure 9) during the process, different combinations 
of volumes and bottles were tested to check what volume was the maximum volume advisable 
to fill the bottles and to assure no losses of sample during the process. 
Observing that the matrix of the sample could be a problem for its density and viscosity, 
different tests were carried out with different dilutions of the blank urine to check if the dilution 
factor could have an effect on the lyophilisation process. It was decided that finally transparent 
bottles (with a capacity of 50 mL) can be filled with 15 mL of blank urine diluted 12,5 % with 
water to assure no losses of sample during the process. Topaz bottles (with a capacity of 10 
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mL) can be filled with 2 mL of blank urine diluted 12,5 % with water also. Finally, topaz bottles 
with a capacity of 30 mL were rejected because the geometry of this container away from the 
normally used by IMIM to prepare reference materials used in interlaboratory comparison. 
All results obtained in tests are summarising in Table 8 situated in appendix 1. 
6.2. QUANTIFICATION STEP AND QUALITY CONTROL SAMPLES 
Results obtained for calibration graphs for all samples are shown in Table 9. All coefficients 
of correlation obtained for each analyte are 0,999 or higher, therefore all calibration curves are 
suitable to calculate the concentrations of urine samples.  
To assure that concentrations obtained were correct, results of quality control samples must 
have been into the acceptance range stipulated by IMIM. In general, the acceptance criterion 
applied is ±20 %, except for THC-COOH where ± 10 % is applied. These quality samples are 
prepared spiking blank urine with an adequate volume of the respective standard solutions, then 
the sample is divided in aliquots and it is introduced in the freezer. The obtained value after 
quantifying 6 aliquots is the nominal value where the acceptance criterion is applied in every 
following analysis until finishing the stored aliquots.  
As it is shown in Table 9, all results obtained for quality control samples were into their 
respective acceptance range. Therefore, quantitative results were accepted. 
 
Analyte Calibration range 
Coefficient of 
correlation 
Results for quality 
samples 
Acceptance range of 
quality samples 
THC-COOH 50-300 ng/mL 0,999 208 ng/mL 192-234 ng/mL 
BE 100-2000 ng/mL 0,999 484 ng/mL 354-532 ng/mL 
EtG 5-100 µg/mL 1,000 92 µg/mL 68-102 µg/mL 
EtS 5-100 µg/mL 1,000 75 µg/mL 60-90 µg/mL 
Table 9. Calibration rage for every analyte, coefficient of correlation obtained, results for quality samples 
obtained and acceptance range of quality samples. 
6.3. HOMOGENEITY STUDIES 
To assure that samples could be used as reference material, samples must comply with an 
essential property, which is homogeneity. 
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To test the homogeneity of the fresh urine sample, 8 aliquots stored at 4 ºC were analyzed 
by duplicate (samples of THC-COOH and BE). Also 8 lyophilized aliquots stored at 4 ºC were 
analyzed by duplicate to test the homogeneity of every lyophilized urine sample. 
Homogeneity was evaluated by applying the two criteria used in IMIM assuring 
homogeneity: a one-way ANOVA test (α = 5 %), and a precision Model of Horwitz. 
According to the protocol established by IMIM if at least one criterion is accepted, the 
sample is regarded as homogeneous. 
The concentrations obtained for every samples of THC-COOH, BE, EtG and EtS are shown 
in Table 10 to Table 13 with their respective units. 
 
Conc. 
ng/mL 
Fresh aliquots of THC-COOH 
1 2 9 10 27 28 35 36 
Rep.1 133,4 120,6 130,7 132,6 134,7 131,0 124,7 125,4 
Rep.2 136,6 114,4 131,7 129,1 132,7 129,2 122,5 125,3 
Conc. 
ng/mL 
Lyophilized aliquots of THC-COOH 
1 2 9 10 27 28 35 36 
Rep.1 137,2 133,3 132,8 141,8 131,2 131,8 134,5 136,0 
Rep.2 139,8 135,1 135,8 138,5 131,9 134,1 130,7 134,3 
Table 10. Concentrations [ng/mL] obtained for fresh and lyophilized aliquots of THC-COOH. 
 
Conc. 
ng/mL 
Fresh aliquots of BE 
1 2 9 10 27 28 35 36 
Rep.1 1341,2 1320,4 1304,7 1337,8 1330,6 1345,6 1348,5 1329,9 
Rep.2 1345,7 1327,6 1321,1 1324,2 1333,3 1311,4 1365,7 1330,8 
Table 11. Concentrations [ng/mL] obtained for fresh and lyophilized aliquots of BE. 
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Conc. 
ng/mL 
Lyophilized aliquots of BE 
1 2 9 10 27 28 35 36 
Rep.1 1361,9 1344,7 1373,8 1326,6 1324,6 1249,5 1279,4 1329,5 
Rep.2 1357,3 1352,6 1336,1 1304,6 1326,1 1270,2 1303,2 1321,4 
Table 11 (cont.). Concentrations [ng/mL] obtained for fresh and lyophilized aliquots of BE. 
 
Conc. 
µg/mL 
Lyophilized aliquots of EtG 
1 2 9 10 27 28 35 36 
Rep.1 10,4 9,7 10,6 10,7 10,0 10,5 9,4 10,9 
Rep.2 10,2 9,5 10,9 10,0 9,1 10,6 10,4 10,5 
Table 12. Concentrations [µg/mL] obtained for lyophilized aliquots of EtG. 
 
Conc. 
µg/mL 
Lyophilized aliquots of EtS 
1 2 9 10 27 28 35 36 
Rep.1 8,6 8,6 8,2 9,5 7,2 7,9 6,8 9,2 
Rep.2 8,4 7,0 8,1 7,7 7,4 9,3 8,0 7,5 
Table 13. Concentrations [µg/mL] obtained for lyophilized aliquots of EtS. 
Analyte Fcal, Fcrit. Test- F Ss/SH<0,3 Horwitz 
THC-COOH 
Fresh 15,04>3,50 NO OK 0,10<0,30 OK 
Lyophilized 5,27>3,50 NO OK 0,05<0,30 OK 
BE 
Fresh 2,80<3,50 OK 0,03<0,30 OK 
Lyophilized 12,07>3,50 NO OK 0,08<0,30 OK 
EtG Lyophilized 2,74<3,50 OK 0,16<0,30 OK 
EtS Lyophilized 1,38<3,50 OK 0,17<0,30 OK 
Table 14. Results obtained for every sample applying criterion one (one-way ANOVA) and criterion two 
(Precision Model of Horwitz). 
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Results obtained for one-way ANOVA and for the precision Model of Horwitz for every 
sample aforementioned are shown in Table 14. 
As it is shown in Table 14 these samples were accepted at least by the second criterion. 
Therefore, it can be said that samples of THC-COOH and BE before being lyophilized are 
homogeneous and could be used as reference material without been lyophilized. 
But one of the main points of this project is assure if prepared samples could be used as 
reference material after being lyophilized. As the results shown, all lyophilized samples listed in 
Table 14 were accepted at least by the second criterion. Therefore, these samples could be 
used as reference material due to all samples are homogeneous even being lyophilized. 
About ethanol, it was impossible to calculate the homogeneity because it was not detected 
in any of the aliquots (detection limit of 0,02 g/L). Ethanol was lost during the lyophilisation 
process. 
6.4. BEHAVIOURS OF STUDIED ANALYTES DURING PROCESSING OF SAMPLES 
It is important to know if during the processing samples a loss of the analyte was produced. 
To study this fact, reference aliquots stored at -20 ºC, fresh aliquots stored at 4 ºC and 
lyophilized aliquots were quantified.  
For THC-COOH and BE, 8 lyophilized aliquots were quantified in duplicate, 8 fresh aliquots 
were quantified in duplicate and finally 1 reference aliquot was quantified in triplicate. For the 
sample spiked with EtG and EtS, 8 lyophilized aliquots were quantified in duplicate, 1 fresh 
aliquot was quantified in triplicate and finally 1 reference aliquot was quantified in triplicate. 
First of all, differences between fresh aliquots and reference aliquots were evaluated. The 
results are shown in Table 15. The results are presented with the mean and the standard 
deviation of every sample. 
As it is shown in Table 15, lower differences between fresh and reference aliquots are 
observed. Therefore, it could be attributed to the variability of the method and not to a loss of 
the analyte. 
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 Reference aliquot Fresh aliquots 
 Mean ± sd Mean ± sd 
THC-COOH* 283 ± 3 ng/mL 257 ± 12 ng/mL 
BE* 1344 ± 21 ng/mL 1332 ± 15 ng/mL 
EtG 11,2 ± 0,3 µg/mL 10,8 ± 0,9 µg/mL 
EtS 9,6 ± 0,5 µg/mL 8,8 ±0,7 µg/mL 
EtOH 4,1 ± 0,1 g/L 4,0 ± 0,1 g/L 
Table 15. Concentration of fresh aliquots (mean ± sd, n = 1 triplicate, *n =8 duplicate) and reference 
aliquots (mean ± sd, n = 1 triplicate). 
To evaluate the possible loss of analyte during the process of lyophilisation, the percentage 
of change of lyophilized aliquots respect to reference aliquots was calculated (see Table 16).  
 
 Lyophilized aliquots 
 Mean ± sd Change (%) 
THC-COOH 270 ± 6 ng/mL -4,6 
BE 1323 ± 34 ng/mL -1,6 
EtG 10,2 ± 0,5 µg/mL -8,9 
EtS 8,1 ± 0,8 µg/mL -15,6 
EtOH - - 
Table 16. Concentration of lyophilized aliquots (mean ± sd, n = 8) and differences (percentage of change) 
respect reference aliquots. 
Comparison of the concentration obtained for the lyophilized samples to that of the 
reference aliquots indicates the loss of some compounds during the process. A 5 % of variability 
of the methods was acceptance to evaluate the percentages of change obtained. 
Minimal differences were detected for THC-COOH and BE, such differences were under the 
variability of the method aforementioned. Therefore, these differences could be attributed to the 
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variability of the method and not to a loss of the compound during the lyophilisation process. If 
these differences are maintained over time (3, 6, 12, 24 and 36 months), they can be attributed 
to the variability of the method. A future study of the stability of the samples would ensure this 
assumption. 
However, higher differences were detected for EtG and EtS. In both cases, such differences 
were over the variability of the method. Due to the sample was homogeneous it couldn’t be 
attributed to a physical loss of analyte during the process but it could be attributed to a chemical 
process. Therefore, part of the loss of these analytes seems to be related with the evaporation 
of them. 
Percentages of change are represented in Figure 10. 
Figure 10. Representation of percentage of change for fresh and lyophilized aliquots. 
About the sample of ethanol the only thing it could be said is that in the process of 
lyophilisation a higher loss of analyte was detected. The completely loss of ethanol is related to 
its high volatility.   
To prepare reference materials of EtG and EtS, it would be necessary to fortify the sample 
taking into account the loss percentage observed. 
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7. CONCLUSIONS 
 After carrying out different tests to choose the best container and volume to 
lyophilize the samples without losses, the transparent bottles filled with 15 mL of 
blank urine 12,5 % and topaz bottles (with a capacity of 10 mL) filled with 2 mL of 
blank urine 12,5 % were selected.  
 The most suitable conditions to lyophilize these samples were a temperature of     
-46 ºC, a pressure of 0,070 mBa and a total time of at least 24 hours. 
 Prepared sample of THC-COOH, BE, EtG and EtS were considered 
homogeneous after being lyophilized. These samples can be consider as 
reference materials. 
 Differences detected in lyophilized samples of THC-COOH and BE were attributed 
to the variability of the method and not to a loss of the compound during the 
lyophilisation process. 
 Differences detected in the lyophilized sample of EtG and EtS seem to be related 
with the evaporation of the analytes due to the homogeneity of it.  
 Ethanol was completely lost during the lyophilisation process due to the high 
volatility of the analyte. 
 Some bottles were prepared and stored to continue the long-term study of stability 
(0, 3, 6, 12, 24, 36 months) of the prepared samples. 
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9. ACRONYMS 
ABP Athlete Biological Passport 
BE Benzoylecgonine 
CE Collision Energy 
CRM Certified Reference Material 
CV Cone Voltage 
ESI Electrospray ionization 
EtG Ethyl glucuronide 
EtOH Ethanol 
EtS Ethyl sulphate 
FAI The World Air Sports Federation 
FIA Federation Internationale de l’Automobile 
FIFA Fédération Internationales de Football Association 
FIM International Motorcycling Federation 
GC/MS Gas chromatography coupled with mass spectrometry 
HFIP Hexafluoroisopropanol 
IAAF International Association of Athletics Federations 
IF International sport Federation 
IMIM Institut Hospital del Mar d’Investigacions Mèdiques 
IOC International Olympic Committee 
ISO Intenational Organization for Standardization 
LC/MS-MS Liquid chromatography coupled with tandem mass spectrometry 
MSTFA N- methyl- N- (trimethylsilyl)trifluoroacetamide 
PFPA Pentafluoropropionic anhydride 
PTS Proficiency Testing Schemes 
QCM Quality Control Material 
RM Reference Material 
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RSD Relative standard deviation 
RT Retention Time 
SIM Selected ion monitoring 
SRM Selected reaction monitoring 
THC Δ9- tetrahydrocannabinol 
THC-COOH 11- nor- Δ9- tetrahydrocannabinol- 9- carboxylic acid 
TMS Trimethylsilyl 
TQMS Triple quadrupole mass spectrometer 
UB Universitat de Barcelona 
UCI Union Cycliste Internationale 
UIM Union Internationale Motornautique 
UV Ultraviolet 
WA World Archery Federation 
WADA World Anti- Doping Agency 
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APPENDIX 1: RESULTS FOR PRELIMINARY TESTS 
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Table 8. Results obtained for preliminary tests for establishing lyophilising conditions. 
  
 
 
 
